Table 1 Patient characteristics at the beginning of the study by baseline iPTH level, all 10 countries
Baseline iPTH*, pg/mL | Total | ||||||
|---|---|---|---|---|---|---|---|
< 75 | ≥ 75 – < 150 | ≥ 150 – ≤ 300 | > 300 – ≤ 600 | > 600 | > 800 | ||
N patients | 1217 | 1365 | 1690 | 1343 | 754 | 472 | 6369 |
Males, n (%) | 641 (53) | 809 (59) | 1019 (60) | 767 (57) | 394 (52) | 233 (49) | 3630 (57) |
Age, years | 63.6 (14.7) | 64.7 (14.1) | 64.2 (14.2) | 62.0 (14.8) | 58.2 (15.7) | 57.5 (15.6) | 63.0 (14.7) |
Dialysis vintage†, months | 43.9 (52.7) | 37.8 (47.2) | 40.9 (53.0) | 49.0 (62.2) | 66.5 (64.8) | 70.6 (64.9) | 45.5 (56.0) |
History, n (%) | |||||||
Diabetes | 352 (29) | 404 (30) | 447 (26) | 276 (21) | 102 (14) | 56 (12) | 1581 (25) |
CVD | 978 (80) | 1075 (79) | 1302 (77) | 1020 (76) | 589 (78) | 368 (78) | 4964 (78) |
CKD aetiology, n (%) | |||||||
Hypertension/vascular | 167 (14) | 189 (14) | 249 (15) | 189 (14) | 92 (12) | 64 (14) | 886 (14) |
Glomerulonephritis | 196 (16) | 234 (17) | 263 (16) | 229 (17) | 146 (19) | 95 (20) | 1068 (17) |
Diabetes | 208 (17) | 208 (15) | 268 (16) | 153 (11) | 54 (7) | 27 (6) | 891 (14) |
Tubulo-interstitial | 178 (15) | 187 (14) | 220 (13) | 171 (13) | 120 (16) | 80 (17) | 876 (14) |
Polycystic kidney disease | 60 (5) | 73 (5) | 100 (6) | 83 (6) | 67 (9) | 43 (9) | 383 (6) |
Miscellaneous | 37 (3) | 40 (3) | 78 (5) | 61 (5) | 34 (5) | 20 (4) | 250 (4) |
Unknown | 257 (21) | 309 (23) | 392 (23) | 348 (26) | 190 (25) | 116 (25) | 1496 (23) |
Missing | 114 (9) | 125 (9) | 120 (7) | 109 (8) | 51 (7) | 27 (6) | 519 (8) |